---
figid: PMC7795958__ijms-22-00265-g002
figtitle: 'Therapeutic potential of taro phytochemicals: Anti-carcinogenic effects
  of taro bioactive compounds on the non-canonical NFKB pathway could be mediated
  by polyphenols'
organisms:
- Colocasia esculenta
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
- Danio rerio
pmcid: PMC7795958
filename: ijms-22-00265-g002.jpg
figlink: pmc/articles/PMC7795958/figure/ijms-22-00265-f002/
number: F2
caption: 'Therapeutic potential of taro phytochemicals: Anti-carcinogenic effects
  of taro bioactive compounds on the non-canonical NF-κB pathway could be mediated
  by polyphenols. Polyphenols can mediate the suppression of NF-κB transcriptional
  factor resulting in the inhibition of pro-inflammatory signaling cascade, apoptosis
  induction, cell proliferation control, and metastasis. inhibitory kappa B kinase
  (IKK); vascular endothelial growth factor (VEGF); B-cell lymphoma 2 (BCL-2); B-cell
  lymphoma X (BCL-X); c-myelocytomatosis (C-MYC).'
papertitle: Anticancer and Immunomodulatory Benefits of Taro (Colocasia esculenta)
  Corms, an Underexploited Tuber Crop.
reftext: Patrícia Ribeiro Pereira, et al. Int J Mol Sci. 2021 Jan;22(1):265.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.5990143
figid_alias: PMC7795958__F2
figtype: Figure
redirect_from: /figures/PMC7795958__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7795958__ijms-22-00265-g002.html
  '@type': Dataset
  description: 'Therapeutic potential of taro phytochemicals: Anti-carcinogenic effects
    of taro bioactive compounds on the non-canonical NF-κB pathway could be mediated
    by polyphenols. Polyphenols can mediate the suppression of NF-κB transcriptional
    factor resulting in the inhibition of pro-inflammatory signaling cascade, apoptosis
    induction, cell proliferation control, and metastasis. inhibitory kappa B kinase
    (IKK); vascular endothelial growth factor (VEGF); B-cell lymphoma 2 (BCL-2); B-cell
    lymphoma X (BCL-X); c-myelocytomatosis (C-MYC).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - NFKB1
  - BCL2
  - MYC
  - TNF
  - PTGS2
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - IKKepsilon
  - key
  - IKKbeta
  - dl
  - wash
  - Hrb27C
  - betaTub60D
  - Rpt5
  - DCTN2-p50
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Dif
  - Rel
  - Debcl
  - Myc
  - egr
  - COX2
  - kita
  - ngfra
  - rela
  - nfkb1
  - pak2a
  - itpka
  - vegfaa
  - bcl2a
  - myca
  - tnfb
  - Polyphenols
  - Chronic inflammation
  - tumor
---
